Close Menu

NEW YORK — French diagnostics firm Novacyt said on Wednesday that it has signed an agreement for a €5.0 million ($5.5 million) secured loan.

The loan is being provided by Harbert European Growth Capital (HEGC). Under the terms of the deal, the four-year loan has a fixed 11 percent annual interest rate and HEGC will receive warrants for around 6 million shares of Novacyt, representing 8.5 percent of the principal loan amount.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.